This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The evolution of clinical trials for infant acute lymphoblastic leukemia
Blood Cancer Journal Open Access 11 April 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Leung W, Pitts N, Burnette K et al. Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome Bone Marrow Transplant 2001 27: 717 722
Leung W, Hudson MM, Strickland DK et al. Late effects oof treatment in survivors of childhood acute myeloid leukemia J Clin Oncol 2000 18: 3273 3279
Cohen A, Rovelli A, Bakker B et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the working party for late effects – EBMT Blood 1999 93: 4109 4115
Marco F, Bureo E, Ortega J et al. High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support J Clin Oncol 2000 18: 3256 3261
Davies SM, Ramsay NKC, Klein JP et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia J Clin Oncol 2000 18: 340 347
Michel G, Gluckman E, Esperou-Bourdeau H et al. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total body irradiation – a report from the Société Française de Greffe de Moelle J Clin Oncol 1994 12: 1217 1222
Leung W, Hudson M, Zhu Y et al. Late effects in survivors of infant leukemia Leukemia 2000 14: 1185 1190
Leung W, Hudson MM, Strickland DK et al. Late effects of treatment in survivors of childhood acute myeloid leukemia J Clin Oncol 2000 18: 3273 3279
von Bueltzingsloewen A, Esperou-Bourdeau H, Souillet G et al. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Société Française de Greffe de Moelle Bone Marrow Transplant 1995 16: 521 527
Leung W, Pitts N, Burnette K et al. Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome Bone Marrow Transplant 2001 27: 717 722
Marco F, Bureo E, Ortega JJ et al. High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support J Clin Oncol 2000 18: 3256 3261
Blaise D, Maraninchi D, Michallet M et al. Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission Blood 2001 97: 3669 3671
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ayas, M., Belgaumi, A., Al-Mahr, M. et al. Allogeneic BMT for infantile acute leukemia: what is the optimal conditioning regimen?. Bone Marrow Transplant 29, 630–631 (2002). https://doi.org/10.1038/sj.bmt.1703420
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703420
This article is cited by
-
The evolution of clinical trials for infant acute lymphoblastic leukemia
Blood Cancer Journal (2014)